Login / Signup

Cost Effectiveness of Elderly Pneumococcal Vaccination in Presence of Higher-Valent Pneumococcal Conjugate Childhood Vaccination: Systematic Literature Review with Focus on Methods and Assumptions.

Marina Treskova-SchwarzbachStefan Michael ScholzAlexander Kuhlmann
Published in: PharmacoEconomics (2020)
Methodological approaches and assumptions in modeling VE and the indirect effects of childhood vaccination have a major impact on outcomes of decision-analytic models and cost-effectiveness estimates. Considering recently observed trends in the epidemiology of pneumococcal serotypes, there is currently inconclusive evidence regarding the cost effectiveness of pneumococcal vaccination of the elderly due to lack of studies that model key serotypes such as serotype 3 separately from other groups of serotypes.
Keyphrases
  • middle aged
  • case report
  • early life
  • risk factors
  • type diabetes
  • escherichia coli
  • zika virus
  • decision making
  • childhood cancer
  • skeletal muscle
  • multidrug resistant